[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Biological E\u00e2??s novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2: With four formulations; BECOV2D; BECOV2C;BECOV2B and BECOV2A. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 28.Control Intervention1: None: None", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Biological E\u00e2??s novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2: With four formulations; BECOV2D; BECOV2C;BECOV2B and BECOV2A. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 28.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: None: None", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "2 (day0-28)", "treatment_id": 190, "treatment_name": "Becov2", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Biological E\u00e2??s novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2: With four formulations; BECOV2D; BECOV2C;BECOV2B and BECOV2A. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 28.Control Intervention1: None: None", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Biological E\u00e2??s novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2: With four formulations; BECOV2D; BECOV2C;BECOV2B and BECOV2A. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 28.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: None: None", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]